Ambeed.cn

首页 / / / STAT / SH5-07

SH5-07 {[allProObj[0].p_purity_real_show]}

货号:A427567

SH5-07 is an inhibitor of STAT3 with IC50 of 3.9±0.6 μM with antitumor effects and it can suppresse human glioma and breast cancer.

SH5-07 化学结构 CAS号:1456632-41-9
SH5-07 化学结构
CAS号:1456632-41-9
SH5-07 3D分子结构
CAS号:1456632-41-9
SH5-07 化学结构 CAS号:1456632-41-9
SH5-07 3D分子结构 CAS号:1456632-41-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

SH5-07 纯度/质量文件 产品仅供科研

货号:A427567 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Adv. Funct. Mater., 2025, 2500696. Ambeed. [ A245395 ]
JACS, 2025. Ambeed. [ A505336 ]
Sci. Adv., 2025, 11(13): eadr0006. Ambeed. [ A152627 ]
ACS Appl. Mater. Interfaces, 2025, 17(12): 18046-18058. Ambeed. [ A739356 , A171817 ]
Food Res. Int., 2025, 116191. Ambeed. [ A1452012 ]
更多 >
产品名称 STAT1 STAT3 STAT5 其他靶点 纯度
Nifuroxazide 98%
Fludarabine 98%
Artesunate 98%
BP-1-102 +++

STAT3, Kd: 504 nM

99%+
Niclosamide ++

STAT3, IC50: 0.7 μM

98%
Napabucasin 98%
Cryptotanshinone ++

STAT3, IC50: 4.6 μM

98%
Stattic +

STAT3, IC50: 5.1 μM

98%
NSC 74859 +

STAT3, IC50: 86 μM

99%+
Ochromycinone 98%
HO-3867 97%
C188-9 ++++

STAT3, Kd: 4.7 nM

99%+
HJC0152 99%
SH5-07 97%
SH-4-54 ++++

STAT3, Kd: 300 nM

+++

STAT5, Kd: 464 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

SH5-07 生物活性

靶点
  • STAT3

描述 The signal transducer and activator of transcription (STAT) proteins mediate cytokine and growth factor responses, including promoting cell growth and differentiation, and immune responses[1]. STAT3 is a central transcription factor that is activated by phosphorylation of a conserved tyrosine residue (Tyr705) in response to extracellular cytokines and growth factors and is an attractive target for anticancer drug discovery[2]. SH5-07 is an inhibitor of STAT3 with IC50 of 3.9 ± 0.6 μM[3]. 72-h treatment with SH5-07 of cultured tumor cells harboring variable Stat3 activities inhibited viability to different degrees, with IC50 of 1.0-2.7 μM for glioma U251MG and U87MG cells (most sensitive), 3.8-4.5 μM for breast cancer, MDA-MB-231 (231) cells, 3.8-7.4 μM for glioma, U373MG and SF295 cells, 5.3-5.8 μM for DU145 prostate cancer cells, 4.1-9.2 μM for NIH3T3/v-Src (vSrc), and 9.6-10.3 μM for the least sensitive human pancreatic cancer, Panc-1 cells[3]. Tail vein injection of SH5-07 (5-6 mg/kg every 2-3 days) inhibited growth of 90-150 mm3 established subcutaneous mouse xenografts of human glioma (U251MG) and breast (MDA-MB-231) tumors that harbor aberrantly-active Stat3, with decreased c-Myc, Mcl-1 and Cyclin D1 expression. No significant changes in body weights, blood cell counts, or the gross anatomy of organs, or obvious signs of toxicity were observed[3].
作用机制 SH5-07 blocks STAT3 DNA binding activity.

SH5-07 细胞研究

细胞系 浓度 检测类型 检测时间 活性说明 数据源
127EF cells Cytotoxicity assay Cytotoxicity against human 127EF cells assessed as cell viability after 3 days by Alamar Blue assay, IC50=0.1955 μM 24900612
147EF cells Function assay 2 to 72 hrs Inhibition of STAT3 in human 147EF cells assessed as reduction of phosphorylated Bcl-xL level after 2 to 72 hrs by Western blotting analysis 24900612
25EF cells Cytotoxicity assay Cytotoxicity against human 25EF cells assessed as cell viability after 3 days by Alamar Blue assay, IC50=1.1205 μM 24900612
30M cells Cytotoxicity assay Cytotoxicity against human 30M cells assessed as cell viability after 3 days by Alamar Blue assay, IC50=0.1 μM 24900612

SH5-07 参考文献

[1]Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000 May 15;19(21):2468-73. doi: 10.1038/sj.onc.1203476. PMID: 10851045.

[2]Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994 Jun 3;264(5164):1415-21. doi: 10.1126/science.8197455. PMID: 8197455.

[3]Yue P, Lopez-Tapia F, Paladino D, Li Y, Chen CH, Namanja AT, Hilliard T, Chen Y, Tius MA, Turkson J. Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo. Cancer Res. 2016 Feb 1;76(3):652-63. doi: 10.1158/0008-5472.CAN-14-3558. Epub 2015 Jun 18. PMID: 26088127; PMCID: PMC4684502.

SH5-07 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.60mL

0.32mL

0.16mL

7.99mL

1.60mL

0.80mL

15.98mL

3.20mL

1.60mL

SH5-07 技术信息

CAS号1456632-41-9
分子式C29H28F5N3O5S
分子量 625.61
SMILES Code O=C(NO)C1=CC=C(N(CC2=CC=C(C3CCCCC3)C=C2)C(CN(C)S(=O)(C4=C(F)C(F)=C(F)C(F)=C4F)=O)=O)C=C1
MDL No. MFCD30718177
别名
运输蓝冰
InChI Key QPSUYVALAOXFGL-UHFFFAOYSA-N
Pubchem ID 72550504
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Inert atmosphere, store in freezer, under -20°C

溶解方案

DMSO: 50 mg/mL(79.92 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。